DUBLIN--(BUSINESS WIRE)--The "Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product, Wound Type, and End User" report has been added to ResearchAndMarkets.com's offering.
According to this report the global biofilms treatment market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020-2027. The report highlights trends prevailing in the global biofilms treatment market, and the factors driving and restraining the market growth.
The global biofilms treatment market, based on wound type, is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds. In 2019, the traumatic and surgical wounds segment accounted for the highest share of the market. The market growth for this segment is attributed to the increasing incidence of traumatic and surgical injuries, and rising awareness of benefits provided by wound care products.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biofilms treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global biofilms treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Market Dynamics
- Rising Incidence of Chronic, Surgical, and Traumatic Wounds
- Increasing Number of Burn Injuries
- High Cost of Treating Wounds
- Increasing Research on Biofilm Treatment in Emerging Economies
- Development of Novel Technologies
Companies Mentioned
- Smith & Nephew plc
- MiMedx Group Inc.
- ConvaTec Group plc
- Coloplast A/S
- Molnlycke Healthcare AB
- Organogenesis Holdings Inc.
- Integra LifeSciences Holdings Corporation
- B. Braun Melsungen AG
- PAUL HARTMANN AG
- Medline Industries Inc.
For more information about this report visit https://www.researchandmarkets.com/r/agzjsb
